Related Experiment Video
Updated: Jul 9, 2026
09:06
Expanding Nanopatterned Substrates Using Stitch Technique for Nanotopographical Modulation of Cell Behavior
Published on: December 8, 2016
Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles
Luz Cristal Glangchai1, Mary Caldorera-Moore, Li Shi
1Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712, USA.
Summary
Researchers developed a new method to create precisely controlled, enzyme-triggered nanoparticles for targeted drug delivery. This breakthrough enables simultaneous control over nanoparticle size, shape, and drug release for improved therapeutic applications.
Area of Science:
- Biotechnology
- Nanotechnology
- Materials Science
Background:
- Precise control over nanoscale carrier properties (size, shape, composition) is crucial for effective in-vivo transport, biodistribution, and drug release.
- Shape-specific, "smart" nanoparticles responding to disease signals offer potential for improved therapeutic care in complex diseases.
- Existing nanoparticle synthesis methods lack simultaneous control over size, shape, and environmentally-triggered release, particularly for sub-100 nm particles.
Purpose of the Study:
- To develop a high-throughput nanofabrication technique for producing monodisperse nanoparticles with controlled size and shape.
- To enable environmentally-triggered (enzymatically) release of encapsulated biomolecules.
- To demonstrate the simultaneous control over nanoparticle characteristics and triggered release for potential disease-controlled delivery.
Main Methods:
- Utilized a high-throughput nanofabrication technique employing synthetic and biological macromers (peptides).
- Fabricated highly monodisperse nanoparticles with precise sizes and shapes, down to 50 nm, on silicon wafers.
- Developed a biocompatible, one-step release technique to harvest nanoparticles into aqueous buffers.
Main Results:
- Successfully fabricated nanoparticles with controlled size and shape using peptide-based macromers.
- Demonstrated successful encapsulation of antibodies and nucleic acids within the nanoparticles.
- Achieved precisely controlled, enzyme-triggered release of encapsulated biomolecules from the nanoparticles.
Conclusions:
- The developed nanofabrication technique allows for simultaneous control over nanoparticle size, shape, and composition.
- The nanoparticles exhibit biocompatible properties and enable controlled, enzyme-triggered release of biomolecules.
- This technology holds potential for advanced, disease-controlled delivery of therapeutics and imaging agents.
